Jiuzhou Pharma is proud to announce that we have been awarded the prestigious Gold Medal in the 2024 EcoVadis Sustainability Assessment, a recognition that places us among the top 5% of companies globally for our exceptional performance in Environmental Stewardship, Labor & Human Rights, Business Ethics, and Sustainable Procurement. This milestone underscores our technical leadership in green pharmaceutical manufacturing and our commitment to setting the standard for sustainability within the contract development and manufacturing (CDMO) industry.

As one of the few Chinese CDMOs to achieve this elite Gold rating, Jiuzhou Pharma surpasses industry norms and regulatory expectations, ensuring our global customers benefit from a partner who prioritizes environmental responsibility, operational transparency, and sustainable business practices.

Advancing Green Chemistry & Sustainable Pharmaceutical Manufacturing

At Jiuzhou Pharma, sustainability is deeply embedded in our technical and operational strategies. Our high EcoVadis score of 76 reflects our continuous advancements in:

Green Chemistry & Process Optimization – We integrate atom economy, solvent recovery, and energy-efficient synthesis to minimize environmental impact while enhancing process efficiency.
Carbon Reduction Initiatives – In early 2025, we formally committed to the Science-Based Carbon Target Initiative (SBTi), aligning our operations with global climate action frameworks to reduce greenhouse gas emissions and achieve net-zero goals.

Sustainable Waste Management – We implement closed-loop waste recovery, optimized effluent treatment, and resource recycling strategies to reduce environmental burden.

Stringent ESG Compliance – Our EcoVadis Gold certification ensures that our supply chain, operational ethics, and corporate governance align with the highest global sustainability benchmarks, de-risking supply chain commitments for our partners.

A Competitive Edge in Sustainable CDMO Services

As global regulatory bodies and multinational pharmaceutical companies increasingly mandate stringent ESG (Environmental, Social, and Governance) compliance, Jiuzhou Pharma’s Gold rating offers a competitive advantage to our partners:

🔹 Regulatory Readiness – Our sustainability practices align with European Green Deal policies, REACH regulations, and evolving FDA and EMA environmental directives, ensuring seamless regulatory compliance.

🔹 Supply Chain Transparency & Reliability – Our EcoVadis Gold status demonstrates a mature, responsible, and verifiable ESG framework, giving customers confidence in our ethical sourcing and manufacturing practices.

🔹 Energy-Efficient API & Intermediate Manufacturing – We implement process intensification, solvent minimization, and biocatalysis technologies to improve efficiency and reduce environmental footprint in complex API synthesis.

Commitment to Continuous Improvement & Innovation

Beyond this Gold rating, Jiuzhou Pharma continues to push the boundaries of sustainable pharmaceutical manufacturing. Our commitment to continuous innovation in green chemistry, lifecycle impact reduction, and responsible global manufacturing ensures that we remain a trusted, forward-thinking CDMO partner for the future of pharmaceuticals.

For companies seeking a technically advanced, environmentally responsible, and globally compliant CDMO partner, Jiuzhou Pharma is the clear choice. Learn more about our sustainable manufacturing capabilities and how we can support your next project.
 

Jiuzhou Pharma is proud to announce that we have been awarded the prestigious Gold Medal in the 2024 EcoVadis Sustainability Assessment, a recognition that places us among the top 5% of companies globally for our exceptional performance in Environmental Stewardship, Labor & Human Rights, Business Ethics, and Sustainable Procurement. This milestone underscores our technical leadership in green pharmaceutical manufacturing and our commitment to setting the standard for sustainability within the contract development and manufacturing (CDMO) industry.

As one of the few Chinese CDMOs to achieve this elite Gold rating, Jiuzhou Pharma surpasses industry norms and regulatory expectations, ensuring our global customers benefit from a partner who prioritizes environmental responsibility, operational transparency, and sustainable business practices.

Advancing Green Chemistry & Sustainable Pharmaceutical Manufacturing

At Jiuzhou Pharma, sustainability is deeply embedded in our technical and operational strategies. Our high EcoVadis score of 76 reflects our continuous advancements in:

Green Chemistry & Process Optimization – We integrate atom economy, solvent recovery, and energy-efficient synthesis to minimize environmental impact while enhancing process efficiency.
Carbon Reduction Initiatives – In early 2025, we formally committed to the Science-Based Carbon Target Initiative (SBTi), aligning our operations with global climate action frameworks to reduce greenhouse gas emissions and achieve net-zero goals.

Sustainable Waste Management – We implement closed-loop waste recovery, optimized effluent treatment, and resource recycling strategies to reduce environmental burden.

Stringent ESG Compliance – Our EcoVadis Gold certification ensures that our supply chain, operational ethics, and corporate governance align with the highest global sustainability benchmarks, de-risking supply chain commitments for our partners.

A Competitive Edge in Sustainable CDMO Services

As global regulatory bodies and multinational pharmaceutical companies increasingly mandate stringent ESG (Environmental, Social, and Governance) compliance, Jiuzhou Pharma’s Gold rating offers a competitive advantage to our partners:

🔹 Regulatory Readiness – Our sustainability practices align with European Green Deal policies, REACH regulations, and evolving FDA and EMA environmental directives, ensuring seamless regulatory compliance.

🔹 Supply Chain Transparency & Reliability – Our EcoVadis Gold status demonstrates a mature, responsible, and verifiable ESG framework, giving customers confidence in our ethical sourcing and manufacturing practices.

🔹 Energy-Efficient API & Intermediate Manufacturing – We implement process intensification, solvent minimization, and biocatalysis technologies to improve efficiency and reduce environmental footprint in complex API synthesis.

Commitment to Continuous Improvement & Innovation

Beyond this Gold rating, Jiuzhou Pharma continues to push the boundaries of sustainable pharmaceutical manufacturing. Our commitment to continuous innovation in green chemistry, lifecycle impact reduction, and responsible global manufacturing ensures that we remain a trusted, forward-thinking CDMO partner for the future of pharmaceuticals.

For companies seeking a technically advanced, environmentally responsible, and globally compliant CDMO partner, Jiuzhou Pharma is the clear choice. Learn more about our sustainable manufacturing capabilities and how we can support your next project.
 

Jiuzhou Pharma is proud to announce that we have been awarded the prestigious Gold Medal in the 2024 EcoVadis Sustainability Assessment, a recognition that places us among the top 5% of companies globally for our exceptional performance in Environmental Stewardship, Labor & Human Rights, Business Ethics, and Sustainable Procurement. This milestone underscores our technical leadership in green pharmaceutical manufacturing and our commitment to setting the standard for sustainability within the contract development and manufacturing (CDMO) industry.

As one of the few Chinese CDMOs to achieve this elite Gold rating, Jiuzhou Pharma surpasses industry norms and regulatory expectations, ensuring our global customers benefit from a partner who prioritizes environmental responsibility, operational transparency, and sustainable business practices.

Advancing Green Chemistry & Sustainable Pharmaceutical Manufacturing

At Jiuzhou Pharma, sustainability is deeply embedded in our technical and operational strategies. Our high EcoVadis score of 76 reflects our continuous advancements in:

Green Chemistry & Process Optimization – We integrate atom economy, solvent recovery, and energy-efficient synthesis to minimize environmental impact while enhancing process efficiency.
Carbon Reduction Initiatives – In early 2025, we formally committed to the Science-Based Carbon Target Initiative (SBTi), aligning our operations with global climate action frameworks to reduce greenhouse gas emissions and achieve net-zero goals.

Sustainable Waste Management – We implement closed-loop waste recovery, optimized effluent treatment, and resource recycling strategies to reduce environmental burden.

Stringent ESG Compliance – Our EcoVadis Gold certification ensures that our supply chain, operational ethics, and corporate governance align with the highest global sustainability benchmarks, de-risking supply chain commitments for our partners.

A Competitive Edge in Sustainable CDMO Services

As global regulatory bodies and multinational pharmaceutical companies increasingly mandate stringent ESG (Environmental, Social, and Governance) compliance, Jiuzhou Pharma’s Gold rating offers a competitive advantage to our partners:

🔹 Regulatory Readiness – Our sustainability practices align with European Green Deal policies, REACH regulations, and evolving FDA and EMA environmental directives, ensuring seamless regulatory compliance.

🔹 Supply Chain Transparency & Reliability – Our EcoVadis Gold status demonstrates a mature, responsible, and verifiable ESG framework, giving customers confidence in our ethical sourcing and manufacturing practices.

🔹 Energy-Efficient API & Intermediate Manufacturing – We implement process intensification, solvent minimization, and biocatalysis technologies to improve efficiency and reduce environmental footprint in complex API synthesis.

Commitment to Continuous Improvement & Innovation

Beyond this Gold rating, Jiuzhou Pharma continues to push the boundaries of sustainable pharmaceutical manufacturing. Our commitment to continuous innovation in green chemistry, lifecycle impact reduction, and responsible global manufacturing ensures that we remain a trusted, forward-thinking CDMO partner for the future of pharmaceuticals.

For companies seeking a technically advanced, environmentally responsible, and globally compliant CDMO partner, Jiuzhou Pharma is the clear choice. Learn more about our sustainable manufacturing capabilities and how we can support your next project.